
Economic evaluation of high-dose (80 mg/day) atorvastatin treatment compared with standard-dose (20 mg/day to 40 mg/day) simvastatin treatment in Canada based on the Incremental Decrease in End-Points Through Aggressive Lipid-Lowering (IDEAL) trial
Monika Wagner, Peter Lindgren, Elizabeth Merikle, Mireille Goetghebeur, Bengt JönssonVolume:
25
Année:
2009
DOI:
10.1016/s0828-282x(09)70159-x
Fichier:
PDF, 856 KB
2009